KRAS and pancreatic neoplasm: While our study demonstrates that the Do‐Cy nanocomplex is preferentially internalized by KRAS‐mutant pancreatic cancer cells through elevated macropinocytosis, the underlying mechanism of macropinocytosis is not unique to PCCs.